It was reported that MCP-1 released from astrocytes can reduce neuronal damage (16, 51), and in animal models of AD, it plays a major role in plaque clearance and macrophage recruitment (52), suggesting a neuroprotective role in the CNS. Here, CCL2 is linked to Alzheimer disease.